Recurrence of hepatitis C virus after loss of virus-specific CD4+ T-cell response in acute hepatitis C

Alter, 1997, Epidemiology of hepatitis C, Hepatology, 26, 62S, 10.1002/hep.510260711 Hoofnagle, 1997, Hepatitis C: the clinical spectrum of disease, Hepatology, 26, 15S, 10.1002/hep.510260703 Di Bisceglie, 1994, Development of hepatocellular carcinoma among patients with chronic liver disease due to hepatitis C viral infection, J Clin Gastroenterol, 19, 222, 10.1097/00004836-199410000-00011 Diepolder, 1995, Possible mechanism involving T-lymphocyte response to nonstructural protein 3 in viral clearance in acute hepatitis C virus infection, Lancet, 346, 1006, 10.1016/S0140-6736(95)91691-1 Missale, 1996, Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response, J Clin Invest, 98, 706, 10.1172/JCI118842 Tsai, 1997, Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity, Hepatology, 25, 449, 10.1002/hep.510250233 Koziel, 1992, Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis, J Immunol, 149, 3339 Gruber, 1993, Reactivation of chronic hepatitis C after withdrawal of immunosuppressive therapy, J Intern Med, 234, 223, 10.1111/j.1365-2796.1993.tb00734.x Eyster, 1993, Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study, J Acquir Immune Defic Syndr Hum Retrovirol, 6, 602 Thomas, 1996, Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users, J Infect Dis, 174, 690, 10.1093/infdis/174.4.690 Krawczynski, 1996, Effect of immune globulin on the prevention of experimental hepatitis C virus infection, J Infect Dis, 173, 822, 10.1093/infdis/173.4.822 Yoshioka, 1991, Anti-hepatitis C antibodies in patients with chronic non-A, non-B hepatitis: relation to disease progression and effect of interferon alpha, Am J Gastroenterol, 86, 1495 Diepolder, 1997, Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection, J Virol, 71, 6011, 10.1128/JVI.71.8.6011-6019.1997 elGhazali, 1993, Number of interleukin 4- and interferon gamma–secreting human T cells reactive with tetanus toxoid and the mycobacterial antigen PPD or phytohemagglutinin: distinct response profiles depending on the type of antigen used for activation, Eur J Immunol, 23, 2740, 10.1002/eji.1830231103 Bertoletti, 1997, Different cytokine profiles of intrahepatic T cells in chronic hepatitis B and hepatitis C virus infections, Gastroenterology, 112, 193, 10.1016/S0016-5085(97)70235-X Topham, 1995, Immune CD4+ T cells promote the clearance of influenza virus from major histocompatibility complex class II −/− respiratory epithelium, J Virol, 70, 1288, 10.1128/JVI.70.2.1288-1291.1996 Planz, 1997, A critical role for neutralizing-antibody–producing B cells, CD4(+) T cells,and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers, Proc Natl Acad Sci USA, 94, 6874, 10.1073/pnas.94.13.6874 Manickan, 1995, Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes, J Immunol, 155, 259 Cardin, 1996, Progressive loss of CD8+ T cell-mediated control of a gamma-herpes virus in the absence of CD4+ T cells, J Exp Med, 184, 863, 10.1084/jem.184.3.863 Ossendorp, 1998, Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors, J Exp Med, 187, 693, 10.1084/jem.187.5.693 Matloubian, 1994, CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection, J Virol, 68, 8056, 10.1128/JVI.68.12.8056-8063.1994 Rehermann, 1996, Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients, J Virol, 70, 7092, 10.1128/JVI.70.10.7092-7102.1996 Koziel, 1993, Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV, J Virol, 67, 7522, 10.1128/JVI.67.12.7522-7532.1993 Koziel, 1995, HLA class I–restricted cytotoxic T lymphocytes specific for hepatitis C virus, J Clin Invest, 96, 2311, 10.1172/JCI118287 Penna, 1996, Long-lasting memory T cell responses following self-limited acute hepatitis B, J Clin Invest, 98, 1185, 10.1172/JCI118902 Eyster, 1994, Increasing hepatitis C virus RNA levels in hemophiliacs: relationship to human immunodeficiency virus infection and liver disease. Multi-center Hemophilia Cohort Study, Blood, 84, 1020, 10.1182/blood.V84.4.1020.1020 Chisari, 1995, Hepatitis B virus immunopathogenesis, Annu Rev Immunol, 13, 29, 10.1146/annurev.iy.13.040195.000333 Milich, 1994, Extrathymic expression of the intracellular hepatitis B core antigen results in T cell tolerance in transgenic mice, J Immunol, 152, 455 Diepolder, 1996, Anergic TH1 clones specific for hepatitis B virus (HBV) core peptides are inhibitory to other HBV core-specific CD4+ T cells in vitro, J Virol, 70, 7540, 10.1128/JVI.70.11.7540-7548.1996 Moskophidis, 1994, MHC class I and non-MHC-linked capacity for generating an anti-viral CTL response determines susceptibility to CTL exhaustion and establishment of virus persistence in mice, J Immunol, 152, 4976 Bertoletti, 1994, Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells, Nature, 369, 407, 10.1038/369407a0